Discover investment opportunities in Stocksunder$2 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocksunder$2 using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocksunder$2 using our Smart AI Filter.
8 stocks found for "Stocksunder$2"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.52 | ±84.5% | -2.2 | 0.00% | |||
0.88 | ±63.0% | -95.7 | 0.00% | |||
1.46 | ±85.2% | -0.9 | 0.00% | |||
0.55 | ±66.4% | -1.5 | 0.00% | |||
0.79 | ±46.9% | -62.2 | 0.00% | |||
1.63 | ±100.0% | -2.5 | 0.00% | |||
2.07 | ±100.0% | -4.2 | 0.00% | |||
1.19 | ±88.4% | -5.2 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What potential growth opportunities exist for OSTX?
A: OSTX operates in the biotech sector, which often offers growth potential due to investment in R&D and innovation. Specific catalysts such as successful clinical trials or regulatory approvals could enhance valuation. However, the high-risk nature of biotech stocks requires careful analysis of OSTX's pipeline and financials.
Q: How does WRN's geographic focus impact its investment appeal?
A: WRN is heavily focused on mining in Canada, potentially offering an advantage due to the country's rich mineral resources and stable regulatory environment. Investors may consider Canada's infrastructure and mining policies when evaluating WRN's geographical strategy.
Q: What are the main risks associated with investing in QNCX?
A: QNCX, being a pharmaceutical company, faces risks including regulatory challenges, high R&D costs, and competitive pressures within the sector. Success largely depends on clinical trial outcomes, which can be unpredictable, adding volatility to the stock.
Q: Does IMUX offer any competitive edge in its sector?
A: IMUX may possess a competitive edge through unique drug formulations or advanced R&D technologies. Analyzing its patent portfolio and collaborating with larger pharmaceutical firms might provide insights into its competitive stance.
Q: How might RVPH fare in varying economic cycles?
A: RVPH, involved in healthcare, might exhibit resilience during economic downturns due to the steady demand for health services. However, the economic environment can affect funding availability for clinical trials and expansion efforts.
Q: Are there specific ESG factors to consider with LUCD?
A: LUCD operates within the tech sector, where data privacy and energy consumption might be key ESG concerns. Investigating LUCD's commitment to ethical data handling and sustainable practices can offer insights into its ESG positioning.